Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by the planning of its 300th surgery with the Episealer® implant in the coming weeks. “Strong clinical results, a growing user group among European surgeons, our 300th implant in production, a significant increase in the interest […]